AMES Bacterial Reverse Mutation

1. Biological Effect: Genotoxicity / Mutagenicity Tests
2. Turnaround time: 6 weeks
3. Sample Requirements:

ISO

240 cm² (test item < 0.5 mm thick);
120 cm² (test item ≥ 0.5 mm thick);
8 grams;
40 ml;
at least 2 test items;

MHLW

20 mL or 8 grams or 120 cm2 or 240 cm2

ISO 10993-3 and ISO 10993-33

The purpose of the study is to determine the potential mutagenic effect of the medical device extract on a panel of bacterial strains (five strains). The test item is extracted and bacteria are exposed to the extract via plate incorporation in the presence or absence of metabolic activation, and then selected for the generation of mutant cells via their lack of requirement for specific amino-acid. For each strain and condition, the numbers of colonies after exposure to the test item are compared to those of a negative control.

Carcinogenicity Testing

How We Work

Discovery & Insight

We begin with an in-depth consultation to understand your needs, challenges, and objectives. This helps us define the right strategy and scientific approach for your project.

Design & Development

Our experts translate your vision into actionable plans — combining innovative research, data, and technology to build precise and reliable solutions.

Delivery & Support

We implement the solution with full transparency and ongoing communication. After delivery, we stay involved — supporting you with optimization, updates, and future improvements.

Contact with us

We’re open to collaboration and research partnerships. Fill out the form — our team will respond as soon as possible.

Location:
Europejski Instytut Biomedyczny sp. z o.o.
ul. Bartycka 63A lok. 6, 00-716 Warszawa

Mail:
contact@ebi.bio

Phone:
+48 22 780 06 32

Get in touch